Fueling the Future: ‘Off the shelf’ cancer treatment; The Fund launches operations in Pittsburgh
- Wugen Inc., a biotech company developing universal “off-the-shelf” cell therapy for the treatment of cancer, has entered into an exclusive license agreement with Washington University in St. Louis for the development of Wugen’s Memory Natural Killer (NK) Cell program.
Columbus, OH-based startup eFuse has raised $6 million in a round led by the Ohio Innovation Fund. The round also attracted investments from professional athletes Odell Beckham Jr., Ezekiel Elliot and Seth Curry.
- VC firm The Fund, which started in New York City in 2018, is launching its Midwest region operations in Pittsburgh. Called The Fund Midwest, it will invest in startups across the entire Midwest region, including in Pittsburgh, Detroit, Cincinnati and Chicago.
- Louisville-based Kare Mobile has landed a $250,000 investment from Render Capital. Kare Mobile, which has developed a proprietary software, uses vans as mobile dental offices.
- Nashville-based medical device startup VenoStent raised a $2.2 million round of funding, led by Creative Ventures. VenoStent has developed an absorbable wrap called SelfWrap, which is designed to reduce failures at the vein-artery or vein-graft junction of dialysis patients.